News & Updates

Show Multimedia Only
Dupilumab-associated ocular surface disease less common in children, teens with AD

Dupilumab-associated ocular surface disease less common in children, teens with AD

18 Jan 2025 byMike Ng

The incidence of ocular surface disease associated with dupilumab treatment for moderate-to-severe atopic dermatitis is lower in children and adolescents than that described in adults, suggests a retrospective review at a tertiary paediatric hospital in Singapore

18 Jan 2025